Abiopharma

🔍 MILLER KEVIN D (Executive)

Company: RCM TECHNOLOGIES, INC. (RCMT)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 1,333 shares of Common Stock at $42.0 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 332,616.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,753 shares of Common Stock at $42.05 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 330,863.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: Represents nondiscretionary sale by a plan established by the Reporting Person on August 12, 2024, in a manner intended to satisfy the requirements of Rule 10b5-1.
• F2: Represents the weighted average of a range of sale prices from $42.00 to $42.04. The reporting person undertakes to provide to the Staff of Securities and Exchange Commission, the Company or any stockholder of the Company, upon request, full information regarding the number of shares sold at each separate price.
• F3: Represents the weighted average of a range of sale prices from $42.00 to $42.15. The reporting person undertakes to provide to the Staff of Securities and Exchange Commission, the Company or any stockholder of the Company, upon request, full information regarding the number of shares sold at each separate price.